---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-024505"
form_type: "8-K"
ticker: "ATXI"
cik: "0001644963"
company_name: "AVENUE THERAPEUTICS, INC."
filed_at: "2025-03-17T23:59:59+00:00"
generated_at: "2026-05-24T15:44:27.898183+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Nasdaq to delist Avenue Therapeutics on March 19; stock to trade on OTC Markets

## Summary
- Nasdaq notified Company it will delist common stock effective at open on March 19, 2025.
- Delisting due to failure to maintain minimum $2.5M stockholders' equity per Nasdaq Rule 5550(b)(1).
- Company failed to meet conditions of Panel exception requiring disclosure of equity-increasing transactions by March 14.
- Common stock (ATXI) expected to begin trading on OTC Markets on March 19, 2025.
- Company will continue filing periodic reports with SEC but warns of uncertain trading liquidity.

## SEC filing metadata
- accession: 0001104659-25-024505
- form_type: 8-K
- ticker: ATXI
- cik: 0001644963
- company_name: AVENUE THERAPEUTICS, INC.
- filed_at: 2025-03-17T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.9
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1644963/000110465925024505/0001104659-25-024505-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1644963/000110465925024505/tm259546d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-024505
- JSON: https://secwatch.observer/filing/0001104659-25-024505.json
- Plain text: https://secwatch.observer/filing/0001104659-25-024505.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.